iShares Bitcoin Trust vs Revolution Medicines Inc. Common Stock — how do they compare? iShares Bitcoin Trust trades at $46.74 (market cap $68.92B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: iShares Bitcoin Trust is the larger of the two by market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 40 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IBIT | RVMD | |
|---|---|---|
Market Cap | $68.92B | $43.07B |
Volume | 46,059,179 | 1,184,841 |
Sector | Crypto-linked | Health |
52-Week High | $68.74 | $221.15 |
52-Week Low | $33.29 | $47.50 |
Typical Hold Time | 40 Days | 0 Days |
Enterprise Value | — | $39.77B |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $47.21, down 2.64% on the day, with technical indicators showing a bullish overall signal driven by moving averages. The stock faces immediate support at $46 and resistance at $48. Recent news highlights strong institutional interest with BlackRock's IBIT recording $196 million in daily inflows on October 1, 2026, signaling renewed investor confidence in Bitcoin-focused investment products.
The outlook remains cautiously optimistic given institutional inflows and technical strength, though the absence of traditional financial metrics like P/E and P/S limits fundamental analysis. Key risks include market volatility and regulatory uncertainty, while analyst sentiment appears mixed with technical indicators favoring bullish momentum near-term.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →